Neurobiology of Aging
Volume 30, Issue 7 , Pages 1099-1113 , July 2009

Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels

  • Marie-Christine Pardon

      Affiliations

    • University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 115 82 30157; fax: +44 115 82 30142.
    • ,
  • Sarir Sarmad

      Affiliations

    • University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    • ,
  • Ivan Rattray

      Affiliations

    • University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    • ,
  • Timothy E. Bates

      Affiliations

    • University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    • ,
  • Gillian A. Scullion

      Affiliations

    • University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    • ,
  • Charles A. Marsden

      Affiliations

    • University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    • ,
  • David A. Barrett

      Affiliations

    • Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, United Kingdom
    • ,
  • James Lowe

      Affiliations

    • Department of Neuropathology, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    • ,
  • David A. Kendall

      Affiliations

    • University of Nottingham Medical School, Institute of Neuroscience, School of Biomedical Sciences, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom

Received 28 March 2007 ,Revised 20 September 2007 ,Accepted 6 October 2007.

References 

  1. Adlard PA, Cotman CW. Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience. 2004;124:985–992
  2. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 2005;25:4217–4221
  3. Ambree O, Touma C, Gortz N, Keyvani K, Paulus W, Palme R, et al. Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice. Neurobiol. Aging. 2006;27:955–964
  4. Backman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain. 2001;124:96–102
  5. Barad M, Gean PW, Lutz B. The role of the amygdala in the extinction of conditioned fear. Biol. Psychiatr. 2006;60:322–328
  6. Bazyan AS, Getsova VM, Orlova NV. Pharmacological reminders of emotional state facilitate the retrieval of traces from amnesiac memory. Neurosci. Behav. Physiol. 2001;31:509–515
  7. Belz EE, Kennell JS, Czambel RK, Rubin RT, Rhodes ME. Environmental enrichment lowers stress-responsive hormones in singly housed male and female rats. Pharmacol. Biochem. Behav. 2003;76:481–486
  8. Castellani RJ, Zhu X, Lee HG, Moreira PI, Perry G, Smith MA. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?. Exp. Rev. Neurother. 2007;7:473–485
  9. Castellano C, Rossi-Arnaud C, Cestari V, Costanzi M. Cannabinoids and memory: animal studies. Curr. Drug Targets CNS Neurol. Disord. 2003;2:389–402
  10. Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005;30:516–524
  11. Clement JP, Darthout N, Nubukpo P. Life events, personality and dementia. Psychol. Neuropsychiatr. Vieil. 2003;1:129–138
  12. Comery TA, Martone RL, Aschmies S, Atchison KP, Diamantidis G, Gong X, et al. Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 2005;25:8898–8902
  13. de Kloet ER, Oitzl MS, Joels M. Stress and cognition: are corticosteroids good or bad guys?. Trends Neurosci. 1999;22:422–426
  14. Dineley KT, Xia X, Bui D, Sweatt JD, Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J. Biol. Chem. 2002;277:22768–22780
  15. Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience. 2004;127:601–609
  16. Fediuc S, Campbell JE, Riddell MC. Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague–Dawley rats. J. Appl. Physiol. 2006;100:1867–1875
  17. Frankland PW, Bontempi B, Talton LE, Kaczmarek L, Silva AJ. The involvement of the anterior cingulate cortex in remote contextual fear memory. Science. 2004;304:881–883
  18. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet. 2006;367:1262–1270
  19. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 2006;26:9047–9056
  20. Hennessy MB, Levine S. Sensitive pituitary–adrenal responsiveness to varying intensities of psychological stimulation. Physiol. Behav. 1978;21:295–297
  21. Hill MN, Gorzalka BB. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?. Behav. Pharmacol. 2005;16:333–352
  22. Hirsch-Reinshagen V, Maia LF, Burgess BL, Blain JF, Naus KE, McIsaac SA, et al. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J. Biol. Chem. 2005;280:43243–43256
  23. Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, et al. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res. 2004;1017:130–136
  24. Izquierdo I, Cammarota M, Vianna MM, Bevilaqua LR. The inhibition of acquired fear. Neurotoxicol. Res. 2004;6:175–188
  25. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006;103:5161–5166
  26. Jeong YH, Park CH, Yoo J, Shin KY, Ahn SM, Kim HS, et al. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. FASEB J. 2006;20:729–731
  27. Jhaveri MD, Richardson D, Kendall DA, Barrett DA, Chapman V. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci. 2006;26:13318–13327
  28. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell. 2005;120:701–713
  29. Maccarrone M, Attina M, Bari M, Cartoni A, Ledent C, Finazzi-Agro A. Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. J. Neurochem. 2001;78:339–348
  30. Maccarrone M, Valverde O, Barbaccia ML, Castane A, Maldonado R, Ledent C, et al. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur. J. Neurosci. 2002;15:1178–1186
  31. Mattson MP, Duan W, Chan SL, Cheng A, Haughey N, Gary DS, et al. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior. Neurobiol. Aging. 2002;23(5):695–705
  32. Mazzola C, Micale V, Drago F. Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur. J. Pharmacol. 2003;477:219–225
  33. Mejia S, Giraldo M, Pineda D, Ardila A, Lopera F. Nongenetic factors as modifiers of the age of onset of familial Alzheimer's disease. Int. Psychogeriatr. 2003;15:337–349
  34. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, et al. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 1993;301:41–52
  35. Moncek F, Duncko R, Johansson BB, Jezova D. Effect of environmental enrichment on stress related systems in rats. J. Neuroendocrinol. 2004;16:423–431
  36. Nader K. Memory traces unbound. Trends Neurosci. 2003;26:65–72
  37. National Center for Chronic Disease Prevention and Health Promotion, 1999. Special focus: Healthy aging. Chronic diseases notes and reports 12.
  38. Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, et al. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur. J. Neurosci. 2006;23:251–260
  39. Pardon MC. Stress and ageing interactions: a paradox in the context of shared etiological and physiopathological processes. Brain Res. Rev. 2007;54(2):251–273
  40. Pardon M-C, Kendall DA, Perez-Diaz F, Duxon MS, Marsden CA. Repeated sensory contact with aggressive mice rapidly leads to an anticipatory increase in core body temperature and physical activity that precedes the onset of aversive responding. Eur. J. Neurosci. 2004;20:1033–1050
  41. Pardon MC, Roberts RE, Marsden CA, Bianchi M, Latif ML, Duxon MS, et al. Social threat and novel cage stress-induced sustained extracellular-regulated kinase1/2 (ERK1/2) phosphorylation but differential modulation of brain-derived neurotrophic factor (BDNF) expression in the hippocampus of NMRI mice. Neuroscience. 2005;132:561–574
  42. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic–pituitary–adrenal axis. Endocrinology. 2004;145:5431–5438
  43. Pazos MR, Nunez E, Benito C, Tolon RM, Romero J. Role of the endocannabinoid system in Alzheimer's disease: new perspectives. Life Sci. 2004;75:1907–1915
  44. Pedersen WA, Flynn ER. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Dis. 2004;17:500–506
  45. Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav. Brain Res. 2007;178:18–28
  46. Pugh PL, Vidgeon-Hart MP, Ashmeade T, Culbert AA, Seymour Z, Perren MJ, et al. Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. J. Neuroinflamm. 2007;4:8
  47. Quirk GJ, Garcia R, Gonzalez-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol. Psychiatr. 2006;60:337–343
  48. Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 2005;25:1904–1913
  49. Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem. 2007;360:216–226
  50. Richardson JC, Kendal CE, Anderson R, Priest F, Gower E, Soden P, et al. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience. 2003;122:213–228
  51. Saura CA, Chen G, Malkani S, Choi SY, Takahashi RH, Zhang D, et al. Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J. Neurosci. 2005;25:6755–6764
  52. Terry RD, Katzman R. Senile dementia of the Alzheimer type. Ann. Neurol. 1983;14:497–506
  53. Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann. Neurol. 2004;55:801–814
  54. van der Stelt M, Mazzola C, Esposito G, Matias I, Petrosino S, De Filippis D, et al. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol. Life Sci. 2006;63:1410–1424
  55. Wang R, Dineley KT, Sweatt JD, Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience. 2004;126:305–312
  56. Wolf SA, Kronenberg G, Lehmann K, Blankenship A, Overall R, Staufenbiel M, et al. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol. Psychiatr. 2006;60:1314–1323
  57. Zheng H, Liu Y, Li W, Yang B, Chen D, Wang X, et al. Beneficial effects of exercise and its molecular mechanisms on depression in rats. Behav. Brain Res. 2006;168:47–55

PII: S0197-4580(07)00403-4

doi: 10.1016/j.neurobiolaging.2007.10.002

Neurobiology of Aging
Volume 30, Issue 7 , Pages 1099-1113 , July 2009

Article Tools

* Image Usage & Resolution